Vietnamnet.vn
Podcast
Sanofi
Update news Sanofi
Multinationals riding high in Vietnam’s pharma landscape
Multinational corporations like Sanofi, GlaxoSmithKline, and Reckitt Benckiser gaining the advantage in Vietnam’s over-the-counter channel, or non-description drugs, in the first quarter of 2020 has in part fuelled their global performance.
Global pharma groups push on with operations
Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation
Drug price hikes in US threaten the same in Vietnam?
Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.
Strict regulations limit foreign drug traders in Vietnam’s market
According to the service commitments form of the WTO, Vietnam did not commit to allow foreign invested enterprises to conduct drug distribution services.
Direct imports for pharma groups
The pharmaceutical market was aroused when French-invested Sanofi Vietnam received the certificate of eligibility for a pharmacy business from the Ministry of Health to directly import drugs to the country.
Vietnam allows foreign firm to import drugs for first time
The license has somewhat shown Vietnam’s relaxed management of drugs market which is likely to reach US$7.7 billion by 2021.
Sanofi tests three-in-one antibody to treat or prevent HIV
A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys.
